The gene encoding phosphodiesterase 4D confers risk of ischemic stroke (original) (raw)

• Sacco, R.L. et al. American Heart Association Prevention Conference. IV. Prevention and Rehabilitation of Stroke. Risk factors. Stroke 28, 1507–1517 (1997).
  Article CAS PubMed Google Scholar
• Bonita, R. Epidemiology of stroke. Lancet 339, 342–344 (1992).
  Article CAS PubMed Google Scholar
• Caplan, L.R. Caplan's Stroke: A Clinical Approach. (Butterworth-Heinemann, Boston, 2000).
  Google Scholar
• Adams, H.P. Jr. et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke 24, 35–41 (1993).
  Article PubMed Google Scholar
• Fisher, C.M. Lacunar strokes and infarcts: a review. Neurology 32, 871–876 (1982).
  Article CAS PubMed Google Scholar
• Alberts, M.J. Genetics of Cerebrovascular Disease (Futura, New York, 1999).
  Google Scholar
• Hassan, A. & Markus, H.S. Genetics and ischaemic stroke. Brain 123, 1784–1812 (2000).
  Article PubMed Google Scholar
• Leys, D. et al. Stroke prevention: management of modifiable vascular risk factors. J. Neurol. 249, 507–517 (2002).
  Article PubMed Google Scholar
• Brass, L.M. & Alberts, M.J. The genetics of cerebrovascular disease. Baillieres Clin. Neurol. 4, 221–245 (1995).
  CAS PubMed Google Scholar
• Tournier-Lasserve, E. et al. Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy maps to chromosome 19q12. Nat. Genet. 3, 256–259 (1993).
  Article CAS PubMed Google Scholar
• Joutel, A. et al. Notch3 mutations in CADASIL, a hereditary adult-onset condition causing stroke and dementia. Nature 383, 707–710 (1996).
  Article CAS PubMed Google Scholar
• Palsdottir, A. et al. Mutation in cystatin C gene causes hereditary brain haemorrhage. Lancet 2, 603–604 (1988).
  Article CAS PubMed Google Scholar
• Levy, E. et al. Mutation of the Alzheimer's disease amyloid gene in hereditary cerebral hemorrhage, Dutch type. Science 248, 1124–1126 (1990).
  Article CAS PubMed Google Scholar
• Gunel, M., Awad, I.A., Anson, J. & Lifton, R.P. Mapping a gene causing cerebral cavernous malformation to 7q11.2–q21. Proc. Natl. Acad. Sci. USA 92, 6620–6624 (1995).
  Article CAS PubMed PubMed Central Google Scholar
• Laberge-le Couteulx, S. et al. Truncating mutations in CCM1, encoding KRIT1, cause hereditary cavernous angiomas. Nat. Genet. 23, 189–193 (1999).
  Article CAS PubMed Google Scholar
• Sahoo, T. et al. Mutations in the gene encoding KRIT1, a Krev-1/rap1a binding protein, cause cerebral cavernous malformations (CCM1). Hum. Mol. Genet. 8, 2325–2333 (1999).
  Article CAS PubMed Google Scholar
• Gretarsdottir, S. et al. Localization of a susceptibility gene for common forms of stroke to 5q12. Am. J. Hum. Genet. 70, 593–603 (2002).
  Article CAS PubMed PubMed Central Google Scholar
• Terwilliger, J.D. & Ott, J. A haplotype-based 'haplotype relative risk' approach to detecting allelic associations. Hum. Hered. 42, 337–346 (1992).
  Article CAS PubMed Google Scholar
• Falk, C.T. & Rubinstein, P. Haplotype relative risks: an easy reliable way to construct a proper control sample for risk calculations. Ann. Hum. Genet. 51 (Pt 3), 227–233 (1987).
  Article CAS PubMed Google Scholar
• Houslay, M.D. & Adams, D.R. PDE4 cAMP phosphodiesterases: modular enzymes that orchestrate signalling cross-talk, desensitization and compartmentalization. Biochem. J. 370, 1–18 (2003).
  Article CAS PubMed PubMed Central Google Scholar
• Liu, H. & Maurice, D.H. Phosphorylation-mediated activation and translocation of the cyclic AMP- specific phosphodiesterase PDE4D3 by cyclic AMP-dependent protein kinase and mitogen-activated protein kinases. A potential mechanism allowing for the coordinated regulation of PDE4D activity and targeting. J. Biol. Chem. 274, 10557–10565 (1999).
  Article CAS PubMed Google Scholar
• Liu, H. et al. Expression of phosphodiesterase 4D (PDE4D) is regulated by both the cyclic AMP-dependent protein kinase and mitogen-activated protein kinase signaling pathways. A potential mechanism allowing for the coordinated regulation of PDE4D activity and expression in cells. J. Biol. Chem. 275, 26615–26624 (2000).
  Article CAS PubMed Google Scholar
• Baillie, G., MacKenzie, S.J. & Houslay, M.D. Phorbol 12-myristate 13-acetate triggers the protein kinase A-mediated phosphorylation and activation of the PDE4D5 cAMP phosphodiesterase in human aortic smooth muscle cells through a route involving extracellular signal regulated kinase (ERK). Mol. Pharmacol. 60, 1100–1111 (2001).
  Article CAS PubMed Google Scholar
• Jin, S.L. & Conti, M. Induction of the cyclic nucleotide phosphodiesterase PDE4B is essential for LPS-activated TNF-α responses. Proc. Natl. Acad. Sci. USA 99, 7628–7633 (2002).
  Article CAS PubMed PubMed Central Google Scholar
• Landells, L.J. et al. Identification and quantification of phosphodiesterase 4 subtypes in CD4 and CD8 lymphocytes from healthy and asthmatic subjects. Br. J. Pharmacol. 133, 722–729 (2001).
  Article CAS PubMed PubMed Central Google Scholar
• Fukumoto, S. et al. Distinct role of cAMP and cGMP in the cell cycle control of vascular smooth muscle cells: cGMP delays cell cycle transition through suppression of cyclin D1 and cyclin-dependent kinase 4 activation. Circ. Res. 85, 985–991 (1999).
  Article CAS PubMed Google Scholar
• Ogawa, S. et al. Hypoxia-induced increased permeability of endothelial monolayers occurs through lowering of cellular cAMP levels. Am. J. Physiol. 262, C546–C554 (1992).
  Article CAS PubMed Google Scholar
• Stelzner, T.J., Weil, J.V. & O'Brien, R.F. Role of cyclic adenosine monophosphate in the induction of endothelial barrier properties. J. Cell Physiol. 139, 157–166 (1989).
  Article CAS PubMed Google Scholar
• Pan, X., Arauz, E., Krzanowski, J.J., Fitzpatrick, D.F. & Polson, J.B. Synergistic interactions between selective pharmacological inhibitors of phosphodiesterase isozyme families PDE III and PDE IV to attenuate proliferation of rat vascular smooth muscle cells. Biochem. Pharmacol. 48, 827–835 (1994).
  Article CAS PubMed Google Scholar
• Palmer, D., Tsoi, K. & Maurice, D.H. Synergistic inhibition of vascular smooth muscle cell migration by phosphodiesterase 3 and phosphodiesterase 4 inhibitors. Circ. Res. 82, 852–861 (1998).
  Article CAS PubMed Google Scholar
• Indolfi, C. et al. Activation of cAMP-PKA signaling in vivo inhibits smooth muscle cell proliferation induced by vascular injury. Nat. Med. 3, 775–779 (1997).
  Article CAS PubMed Google Scholar
• Indolfi, C. et al. 8-chloro-cAMP inhibits smooth muscle cell proliferation in vitro and neointima formation induced by balloon injury in vivo. J. Am. Coll. Cardiol. 36, 288–293 (2000).
  Article CAS PubMed Google Scholar
• Tilley, S.L., Coffman, T.M. & Koller, B.H. Mixed messages: modulation of inflammation and immune responses by prostaglandins and thromboxanes. J. Clin. Invest. 108, 15–23 (2001).
  Article CAS PubMed PubMed Central Google Scholar
• Vicini, E. & Conti, M. Characterization of an intronic promoter of a cyclic adenosine 3′,5′-monophosphate (cAMP)-specific phosphodiesterase gene that confers hormone and cAMP inducibility. Mol. Endocrinol. 11, 839–850 (1997).
  CAS PubMed Google Scholar
• Le Jeune, I.R., Shepherd, M., Van Heeke, G., Houslay, M.D. & Hall, I.P. Cyclic AMP-dependent transcriptional up-regulation of phosphodiesterase 4D5 in human airway smooth muscle cells. Identification and characterization of a novel PDE4D5 promoter. J. Biol. Chem. 277, 35980–35989 (2002).
  Article CAS PubMed Google Scholar
• Gulcher, J.R., Kristjansson, K., Gudbjartsson, H. & Stefansson, K. Protection of privacy by third-party encryption in genetic research in Iceland. Eur. J. Hum. Genet. 8, 739–742 (2000).
  Article CAS PubMed Google Scholar
• Chen, X., Zehnbauer, B., Gnirke, A. & Kwok, P.Y. Fluorescence energy transfer detection as a homogeneous DNA diagnostic method. Proc. Natl. Acad. Sci. USA 94, 10756–10761 (1997).
  Article CAS PubMed PubMed Central Google Scholar
• Risch, N. & Teng, J. The relative power of family-based and case-control designs for linkage disequilibrium studies of complex human diseases I. DNA pooling. Genome Res. 8, 1273–1288 (1998).
  Article CAS PubMed Google Scholar
• Rice, J.A. Generalized likelihood ratio tests. in Mathematical Statistics and Data Analysis 308–310 (International Thomson Publishing, Belmont, California, 1995).
  Google Scholar
• Dempster, A.P., Laird, N.M. & Rubin, D.B. Maximum likelihood estimation from incomplete data via the EM algorithm (with discussion). J. R. Stat. Soc. Ser. B Stat. Med. 39, 1–38 (1971).
  CAS Google Scholar
• Lewontin, R. The interaction of selection and linkage I. General considerations: Heterotic models. Genetics 49, 49–67 (1964).
  CAS PubMed PubMed Central Google Scholar
• Hill, W.G. & Robertson, A. Linkage disequilibrium in finite populations. Theor. Appl. Genet. 22, 226–231 (1968).
  Article Google Scholar